9QCO image
Deposition Date 2025-03-04
Release Date 2025-09-10
Last Version Date 2025-09-10
Entry Detail
PDB ID:
9QCO
Keywords:
Title:
NTNH-HA70 complex from Clostridium botulinum Serotype B1
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.76 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Botulinum neurotoxin type B1, nontoxic-nonhemagglutinin component, NTNH
Gene (Uniprot):ntnH
Chain IDs:A
Chain Length:1197
Number of Molecules:1
Biological Source:Clostridium botulinum
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Hemagglutinin component HA70
Gene (Uniprot):ha70
Chain IDs:B, C, D
Chain Length:626
Number of Molecules:3
Biological Source:Clostridium botulinum
Ligand Molecules
Primary Citation
Structure of the complete 14-subunit botulinum neurotoxin B complex reveals a unique anchoring through the narrow central pore of HA70.
Sci Adv 11 eadx5058 eadx5058 (2025)
PMID: 40864696 DOI: 10.1126/sciadv.adx5058

Abstact

Botulinum neurotoxin serotype B1 (BoNT/B) is a highly potent neurotoxin and therapeutic agent. Here, we present the structure of the complete 14-subunit (780 kDa) progenitor toxin complex (L-PTC) and of five subcomplexes. The structures show how the toxin interacts with its associated components in their role to protect and deliver BoNT/B across epithelial barriers. Each subcomplex, including the M-PTC, M-PTC-HA70, NTNH-HA70, and HA70 trimer, provides detailed understanding of the assembly mechanism, in which the NTNH-nLoop adopts a unique fold that locks the M-PTC into a central pore formed by HA70. The HA subcomplex presents a tripod architecture with flexible legs that may adapt to the rugged cell surface. Mass photometry reveals the pH dependence of BoNT/B release from the complex which is unexpectedly influenced by the presence of HA70. This study provides the complete L-PTC structure, offering insights into its assemblage and supporting the development of countermeasures and therapeutic applications.

Legend

Protein

Chemical

Disease

Primary Citation of related structures